- View All Journals
- Expert Opinion on
- Expert Review of
- Anticancer Therapy
- Anti-infective Therapy
- Cardiovascular Therapy
- Clinical Immunology
- Clinical Pharmacology
- Endocrinology & Metabolism
- Gastroenterology & Hepatology
- Medical Devices
- Molecular Diagnostics
- Obstetrics & Gynecology
- Pharmacoeconomics & Outcomes Research
- Respiratory Medicine
- Current Medical Research and Opinion
- Journal of Medical Economics
- Journal of Drug Assessment
- View All Books
- View Book Series
- Basic and Clinical Dermatology
- BioMed Tracker Reports
- Clinical and Basic Science Dermatology
- Cosmetic Science and Technology
- Drugs and the Pharmaceutical Sciences
- European Society of Medical Oncology
- Fundamental and Clinical Cardiology
- Infectious Disease and Therapy
- Lung Biology in Health and Disease
- Medical Psychiatry
- Reproductive Medicine/Assisted Tech
- Series in Cosmetic and Laser Therapy
- Series in Dermatological Treatment
- Series in Maternal-fetal Medicine
- Target Organ Toxicology
- Translational Medicine
- Encyclopedias and Reference Works
- Expert Opinion on Cardiovascular Disease
- Expert Opinion on Haematology
- Expert Opinion on Infection
- Expert Opinion on Musculoskeletal Disorders
- Expert Opinion on Neurology
- Expert Opinion on Oncology
- Expert Opinion on Psychiatry
- Expert Opinion on Respiratory Disease
- Informa Healthcare Diabetes Collection
Expert Opinion on Therapeutic Targets
About the Journal
Editors-in-Chief: Daniele Santini, University Campus Bio-Medico, Rome, Italy
Commissioning Editor: Claudia Palmer
2012 ISI Impact Factor: 4.130
ISSN: 1472-8222 (print), 1744-7631 (electronic)
- The role of CD33 as therapeutic target in acute myeloid leukemia
Roland B Walter
- Novel genetic targets in endometrial cancer
Daphne W Bell
- The potential of targeting Wnt/β-catenin in colon cancer
- Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps
Peter A Ward
- Apoptosis signal-regulating kinase 1 as a therapeutic target
Annexin A4 as a target for treating platinum-resistant cancersApril 11, 2022
What is FDA approved and what are the new therapeutic targets for treating SLE?April 9, 2022
Look no further than these (some FREE) articles from Expert Opinion’s April issues!
New therapeutic target for psoriasis – IL-23?February 27, 2022An early on line review published in Expert Opinion on Therapeutic Targets discusses the role of IL-23 in the pathogenesis of psoriasis and whether it could be a novel therapeutic target
Highlight of March issue reviews therapeutic targets for treating neuroblastomasFebruary 17, 2022Editor in Chief Danieie Santini picks review on ‘Therapeutic targets for neuroblastomas’ as March highlight from Expert Opinion on Therapeutic Targets!
February’s Editors Pick suggests new therapeutic target for breast cancerFebruary 5, 2022Editor in Chief of Expert Opinion on Therapeutic Targets, Daniele Santini, picks original research investigating the influence of the COX-2/PGE2 pathway on the behaviour of breast cancer cells as February’s pick!
Find out about potential new therapeutic targets for Alzheimer’s disease with Expert Opinion on Therapeutic Targets.January 30, 2022According to the Alzheimer’s Association 2013 more than 5 million Americans are living with Alzheimer’s disease and it is thought that by 2050, the number of people with Alzheimer’s may nearly triple. None of the treatments available today for Alzheimer’s are disease modifying, they are unable to slows or stop the death and malfunction of neurons making the disease fatal.
Editor in Chief picks Protease-activated receptor 2 signalling pathways: a role in pain processing by Yanju Bao, Wei Hou & Baojin Hua as January’s highlightJanuary 9, 2022Daniele Santini chose this paper because ‘Cancer pain is great healthcare problem, with current treatment strategies often failing to obtain acceptable efficacy. One of the major difficulties in treating cancer pain derives from the complex interplay between the cancer microenvironment, cancer therapy, and the personal responses to these biochemical changes’.
Expert Opinion and Expert Reviews are now on facebook!December 18, 2013The Expert Opinion & Expert Reviews journals are now on facebook! Click here to visit our page and ‘LIKE’ us to keep updated of the newest articles and hottest news!
Daniele Santini picks article on Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer therapeutic implications as December highlightDecember 4, 2013Professor Daniele Santini, Editor in Chief of Expert Opinion on Therapeutic targets chooses article on Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer therapeutic implications by Spyros G Pneumaticos, Anthos Christofides, Eliona Gkioka, Theodoros Kalogeropoulos, Pavlos Msaouel and Michael Koutsilieris as December highlight
This Week in Expert Opinion…November 22, 2013This week in the Expert Opinion journals we look at therapeutic targets and methods of targeted therapy from different points of view and stages of drug development.
Highlight of the November issue from the Expert Opinion editorsNovember 19, 2013Gout is an ancient autoinflammatory disease that affects millions of people worldwide. Check out this insightful editorial from Zhenyu Zhong, Yougang Zhai & Liang Qiao, published in the November issue of Expert Opinion on Therapeutic Targets.
This week in Expert OpinionNovember 8, 2013This week in Expert Opinion, we look at the emerging treatments for some of the world’s most prevalent diseases covering: autoimmune, infectious and cardiovascular disease. Click above to find out more.
Top read article in September across Informa Healthcare Journals: Expert Opinion on Biological TherapyOctober 15, 2013An article recently published in Expert Opinion on Biological Therapy on emerging targets in mutiple myeloma is the second most downloaded article in September 2013. For more details on this article, read here!
Editor’s pick – interesting review of epidermal growth factor receptorOctober 4, 2013“Epidermal growth factor receptor: an important target in esophageal cancer” from Liu Hong, Yu Han, and Lubi Brain is the pick of the October issue of Expert Opinion on Therapeutic Targets from our Editor in Chief Daniele Santini (University Campus Bio-Medico). Read more here…
Editorial Highlight for September 2013August 22, 2013Targeting MACC1 in colorectal metastasis by Ulrike Stein
Editor’s Pick for August 2013July 31, 2013Ephrins and pain by Ioanna Vasileiou, Ioannis Adamakis, Efstratios Patsouris & Stamatios Theocharis
Editor’s Pick for July 2013June 14, 2013Targeting TGF-β signaling in cancer by Lior H Katz, Ying Li, Jiun-Sheng Chen, Nina M Muñoz, Avijit Majumdar, Jian Chen & Lopa Mishra
Editor’s Pick for June 2013May 16, 2013CXCR2: a target for pancreatic cancer treatment? by Kathleen M Hertzer, Graham W Donald & O Joe Hines
Editor’s Pick for May 2013April 17, 2013Challenges in drug target discovery in bipolar disorder by Murtada Alsaif, Frieder Haenisch, Paul C Guest, Hassan Rahmoune & Sabine Bahn
MicroRNAs: a big deal for R&DMarch 28, 2013
Several Expert Opinion journals have published articles on miRNAs in the last year with more in the pipeline. This indicates just how important they are in all aspects of research and development and across a variety of therapy areas.
Editor’s Pick for April 2013March 25, 2013Gene expression analysis reveals functional pathways of glatiramer acetate activation by Shlomo Bakshi, Vered Chalifa-Caspi, Inbar Plaschkes, Igor Perevozkin, Michael Gurevich and Riki Schwartz
Editor’s Pick for March 2013February 20, 2013Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients by Donato Santovito et al.
Editorial Highlight for February 2013January 30, 2013Th22 and related cytokines in inflammatory and autoimmune diseases by Tian Tian, Shuang Yu and Daoxin Ma is our editorial highlight for the February issue of EOTT.
Editorial highlight for January 2013December 14, 2012Tumor vasculature: the Achilles heel of cancer? from Eikesdal and colleagues, gives an overview of current applications of anti-angiogenic therapies and their limitations in different solid cancers and is our editorial highlight for the January issue of EOTT
Editorial higlight for November – aiming at DISC1November 23, 2012DISC1 as a therapeutic target of mental illnesses by Akira Sawa from Johns Hopkins University School of Medicine is the editorial team’s highlight of the December issue of Expert Opinion on Therapeutic Targets.
Editorial highlight for November 2012October 11, 2012
This interesting paper talks about recent advances for the treatment of the rare bone cancer disease, chordoma and in particular on the identification of tumor markers.
Novel therapeutic targets in chordoma by Mohamad Bydon, Kyriakos Papadimitriou, Timothy Witham, Jean-Paul Wolinsky, Ali Bydon, Daniel Sciubba & Ziya Gokaslan is our editorial highlisght for the November issue.
Editorial highlight for October 2012 – It’s spicy!October 11, 2012Curcumin: a potential candidate for matrix metalloproteinase inhibitors by Dileep Kumar, Manish Kumar, Chinnadurai Saravanan & Sushil Kumar Singh has been chosed by the editoral team as a highlight of the October issue of Expert Opinion on Therapuetic Targets!
Let’s be clear – Expert Opinion on ethical publishingMarch 27, 2012In the interests of transparency, the editors would like to take the opportunity to update our readers on our ethical policies, and assure you that we take any breach of said policies very serieously, and will will investigate all such issues as fully as possible.
EOTT Editor’s Pick February 2012March 1, 2012Pathophysiologic therapeutic targets in hypertension: a cardiological point of view
‘The article “Pathophysiologic therapeutic targets in hypertension: a cardiological point of view” by Fragasso et al, underlines the holistic approach to hypertension – an important issue of current interest. The choice of blood pressure lowering drugs is also considered.’
Dr Dimitri Mikhailidis, Editor in Chief
Coming Soon: Special Issue on Cancer from Expert Opinion on Therapeutic TargetsJanuary 13, 2012Cancer is one of the most investigated diseases today, with a large amount of research devoted to finding successful therapies.
This January, Expert Opinion on Therapeutic Targets (EOTT) will devote a special issue to the most prevalent targets in cancer therapy, providing an overview and update on the most important issues.
Guest edited by Dr William Cho, an expert in this topic, this issue seeks to unify the many pathway-based approaches currently of interest.